| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1047170197 |
| P356 | DOI | 10.1038/GT.2012.61 |
| P932 | PMC publication ID | 4105013 |
| P698 | PubMed publication ID | 22895508 |
| P2093 | author name string | N R Landau | |
| N Sunseri | |||
| S Bobadilla | |||
| P2860 | cites work | How SAMHD1 changes our view of viral restriction | Q24605899 |
| SAMHD1 is the dendritic- and myeloid-cell-specific HIV-1 restriction factor counteracted by Vpx | Q24605940 | ||
| Transfusion independence and HMGA2 activation after gene therapy of human β-thalassaemia | Q24618997 | ||
| SAMHD1 restricts the replication of human immunodeficiency virus type 1 by depleting the intracellular pool of deoxynucleoside triphosphates | Q24624362 | ||
| Vpx relieves inhibition of HIV-1 infection of macrophages mediated by the SAMHD1 protein | Q24635842 | ||
| Localization of the Vpx packaging signal within the C terminus of the human immunodeficiency virus type 2 Gag precursor protein | Q24645706 | ||
| Gene transfer in humans using a conditionally replicating lentiviral vector | Q24675343 | ||
| HIV-1 restriction factor SAMHD1 is a deoxynucleoside triphosphate triphosphohydrolase | Q27675416 | ||
| A versatile viral system for expression and depletion of proteins in mammalian cells | Q28475909 | ||
| In vivo gene delivery and stable transduction of nondividing cells by a lentiviral vector | Q29547503 | ||
| Germline transmission and tissue-specific expression of transgenes delivered by lentiviral vectors | Q29547596 | ||
| Long-term control of HIV by CCR5 Delta32/Delta32 stem-cell transplantation | Q29615068 | ||
| A third-generation lentivirus vector with a conditional packaging system | Q29616120 | ||
| Aicardi-Goutieres syndrome gene and HIV-1 restriction factor SAMHD1 is a dGTP-regulated deoxynucleotide triphosphohydrolase | Q29871440 | ||
| Lentiviruses as gene transfer agents for delivery to non-dividing cells | Q34754954 | ||
| Hematopoietic stem cell gene therapy with a lentiviral vector in X-linked adrenoleukodystrophy | Q35011497 | ||
| Human immunodeficiency virus type 1 modified to package Simian immunodeficiency virus Vpx efficiently infects macrophages and dendritic cells | Q35077587 | ||
| Heterologous human immunodeficiency virus type 1 lentiviral vectors packaging a simian immunodeficiency virus-derived genome display a specific postentry transduction defect in dendritic cells. | Q35803032 | ||
| HER-2 pulsed dendritic cell vaccine can eliminate HER-2 expression and impact ductal carcinoma in situ. | Q35899068 | ||
| Regulatory considerations for novel gene therapy products: a review of the process leading to the first clinical lentiviral vector | Q36036225 | ||
| Human immunodeficiency virus pseudotypes with expanded cellular and species tropism | Q36806036 | ||
| Characterization of simian immunodeficiency virus SIVSM/human immunodeficiency virus type 2 Vpx function in human myeloid cells | Q36994727 | ||
| A single amino acid of APOBEC3G controls its species-specific interaction with virion infectivity factor (Vif). | Q37095343 | ||
| Evidence for an activation domain at the amino terminus of simian immunodeficiency virus Vpx. | Q38348781 | ||
| Enforced viral replication activates adaptive immunity and is essential for the control of a cytopathic virus | Q39439883 | ||
| The cargo-binding domain of transportin 3 is required for lentivirus nuclear import | Q39462609 | ||
| SIVSM/HIV-2 Vpx proteins promote retroviral escape from a proteasome-dependent restriction pathway present in human dendritic cells | Q40185026 | ||
| With a little help from a friend: increasing HIV transduction of monocyte-derived dendritic cells with virion-like particles of SIV(MAC). | Q40307361 | ||
| Phenotypic mixing between human immunodeficiency virus and vesicular stomatitis virus or herpes simplex virus | Q41753189 | ||
| Chimeric Antigen Receptor Therapy for B-cell Malignancies | Q42766326 | ||
| Gene therapy of x-linked adrenoleukodystrophy using hematopoietic stem cells and a lentiviral vector | Q42776697 | ||
| Vaccination with autologous dendritic cells pulsed with multiple tumor antigens for treatment of patients with malignant melanoma: results from a phase I/II trial | Q43080246 | ||
| Gene transfer by lentiviral vectors is limited by nuclear translocation and rescued by HIV-1 pol sequences | Q44491759 | ||
| Repression of the human immunodeficiency virus type 1 promoter by the human KRAB domain results in inhibition of virus production. | Q45749514 | ||
| DCVax-Brain and DC vaccines in the treatment of GBM | Q83589224 | ||
| A simple, versatile and efficient method to genetically modify human monocyte-derived dendritic cells with HIV-1-derived lentiviral vectors | Q84261542 | ||
| P433 | issue | 5 | |
| P304 | page(s) | 514-520 | |
| P577 | publication date | 2012-08-16 | |
| P1433 | published in | Gene Therapy | Q15763095 |
| P1476 | title | Efficient transduction of myeloid cells by an HIV-1-derived lentiviral vector that packages the Vpx accessory protein | |
| P478 | volume | 20 |
| Q39128552 | A Highly Active Isoform of Lentivirus Restriction Factor SAMHD1 in Mouse |
| Q38693747 | A combination HIV reporter virus system for measuring post-entry event efficiency and viral outcome in primary CD4+ T cell subsets |
| Q34469817 | A nonintegrative lentiviral vector-based vaccine provides long-term sterile protection against malaria |
| Q61815216 | A novel splice mutation induces exon skipping of the EXT1 gene in patients with hereditary multiple exostoses |
| Q97529378 | Antiviral immunity and nucleic acid sensing in haematopoietic stem cell gene engineering |
| Q60306229 | Cyclosporine H Overcomes Innate Immune Restrictions to Improve Lentiviral Transduction and Gene Editing In Human Hematopoietic Stem Cells |
| Q38900861 | Degradation of SAMHD1 by Vpx Is Independent of Uncoating |
| Q44483910 | Dendritic cell immunotherapy |
| Q89347786 | Dendritic cell-based immunotherapy |
| Q36202747 | Differential regulatory activities of viral protein X for anti-viral efficacy of nucleos(t)ide reverse transcriptase inhibitors in monocyte-derived macrophages and activated CD4(+) T cells |
| Q55515225 | Efficient Transduction and Expansion of Ovine Macrophages for Gene Therapy Implementations. |
| Q37735112 | Efficient delivery of lentiviral vectors into resting human CD4 T cells |
| Q97644521 | Generation of Powerful Human Tolerogenic Dendritic Cells by Lentiviral-Mediated IL-10 Gene Transfer |
| Q37543254 | HIV type 1 infection of plasmacytoid and myeloid dendritic cells is restricted by high levels of SAMHD1 and cannot be counteracted by Vpx. |
| Q40922628 | HIV-1 Vpr- and Reverse Transcription-Induced Apoptosis in Resting Peripheral Blood CD4 T Cells and Protection by Common Gamma-Chain Cytokines |
| Q34795512 | Host factor SAMHD1 restricts DNA viruses in non-dividing myeloid cells |
| Q94496792 | Human chimeric antigen receptor macrophages for cancer immunotherapy |
| Q24567990 | IFI16 DNA sensor is required for death of lymphoid CD4 T cells abortively infected with HIV |
| Q60913086 | Incomplete Suppression of HIV-1 by SAMHD1 Permits Efficient Macrophage Infection |
| Q30954229 | Intrinsic host restrictions to HIV-1 and mechanisms of viral escape. |
| Q92952368 | Lentiviral Vector-Based Dendritic Cell Vaccine Suppresses HIV Replication in Humanized Mice |
| Q96124007 | Lentiviral-Vector-Based Dendritic Cell Vaccine Synergizes with Checkpoint Blockade to Clear Chronic Viral Infection |
| Q35600854 | Macrophage-specific overexpression of interleukin-5 attenuates atherosclerosis in LDL receptor-deficient mice |
| Q26742169 | Recent Advances in Lentiviral Vaccines for HIV-1 Infection |
| Q35107612 | SAMHD1 restricts HIV-1 replication and regulates interferon production in mouse myeloid cells |
| Q37350713 | The feasibility of incorporating Vpx into lentiviral gene therapy vectors. |
| Q56336950 | Toll-like receptor agonist R848 blocks Zika virus replication by inducing the antiviral protein viperin |
| Q92734574 | Vpr Enhances HIV-1 Env Processing and Virion Infectivity in Macrophages by Modulating TET2-Dependent IFITM3 Expression |
| Q89043272 | Vpr Targets TET2 for Degradation by CRL4VprBP E3 Ligase to Sustain IL-6 Expression and Enhance HIV-1 Replication |
| Q41347747 | Vpx-containing dendritic cell vaccine induces CTLs and reactivates latent HIV-1 in vitro |
Search more.